Pediatric Hematology/Oncology

Dermatology

Questions discussed in this category

How would you work up a patient with cutaneous mastocytosis?

Is a BM biopsy a must when there is skin involvement? If tryptase level is mildly elevated but less than 20 would you recommend a BM biopsy?

1 Answer available

What systemic therapy would you offer a patient with metastatic melanoma who is BRAF WT and developed metastases while on adjuvant nivolumab?

2 Answers available

How do you approach melanoma patients with a positive sentinel node with extra-nodal extension for definitive surgical management?

Is completing nodal dissection warranted for surgical management?

1 Answer available

Does IVIG or subcutaneous Ig interfere with monoclonal antibody therapy (i.e. dupilumab, infliximab, rituximab, etc)?

How should IVIG and either biologic injections or infusions be spaced?

2 Answers available

What surveillance plan would you recommend for stage IV melanoma patients who achieve a CR or stable PR response with immunotherapy?

1 Answer available

How do you manage patients with chemotherapy-induced paronychia?

1 Answer available

Is there an age cut off below you would not treat a keloid with radiation post surgical excision?

Assuming it has previously been treated with excision and steroid injections? Is it reasonable to treat a bothersome keloid in a pediatric patient aft...

6 Answers available

Papers discussed in this category

Br J Radiol,

The risks of treating keloids with radiotherapy.

Burns, 2014 Apr 24

Up-to-date approach to manage keloids and hypertrophic scars: a useful guide.

Pediatrics, 2013-01

Nine-month-old patient with bilateral earlobe keloids.

Pediatrics, 2016-02

Scar Management in the Pediatric and Adolescent Populations.

International journal of radiation oncology, biology, physics, 2018-09-01

Dose Effect in Adjuvant Radiation Therapy for the Treatment of Resected Keloids.

Eur J Dermatol,

Telangiectasia macularis eruptiva perstans: a neglected type of mastocytosis with exclusively cutaneous involvement? A case series.

Clinical pharmacokinetics, 2018-12

Infliximab Pharmacokinetics are Influenced by Intravenous Immunoglobulin Administration in Patients with Kawasaki Disease.

Frontiers in immunology, 2018

Reversing Autoimmunity Combination of Rituximab and Intravenous Immunoglobulin.

Clinical immunology (Orlando, Fla.), 2020 Jul 15

The potential impact of timing of IVIG administration on the efficacy of rituximab for immune tolerance induction for patients with Pompe disease.

The Pediatric infectious disease journal, 2018 Oct

Infliximab Plus Intravenous Immunoglobulin (IVIG) Versus IVIG Alone as Initial Therapy in Children With Kawasaki Disease Presenting With Coronary Artery Lesions: Is Dual Therapy More Effective?

Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology, 2017 Nov 03

Successful IVIG treatment without discontinuation of TNF-α blocker in Guillain-Barre syndrome induced by adalimumab in patient with Crohn's disease.

European journal of cancer (Oxford, England : 1990), 2017-04

Ipilimumab alone or in combination with nivolumab after progression on anti-PD-1 therapy in advanced melanoma.

N Engl J Med, 2017 Jun 8

Completion Dissection or Observation for Sentinel-Node Metastasis in Melanoma.

Pediatric Hematology/Oncology

Dermatology

Questions discussed in this category

Papers discussed in this category

Related Topics in Pediatric Hematology/Oncology